Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Latest in Premium

See all
Natco-Pharma.jpg

Cracking the Patent Code: Natco’s Winning Formula

Natco Pharma, a leader in APIs and niche generics, faces growth challenges post-Revlimid exclusivity in FY26, with semaglutide offering long-term ...

Join Capitalmind Premium

Starts at ₹1,999/mo
Subscribe Now Or start with a free-trial

Actionable investing insights

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community

Recent Posts

Stocks

Jubilant Pharmova: At the Crossroads of Change

Jubilant Pharmova is a multifaceted pharma player, standing amidst a blend of growth and transformation. While some its segments are showing robust growth ...
Group-96.jpg
Stocks

Waaree Energies: Powering India's solar sector growth

The renewable energy world is changing fast, and Waaree Energies is leading the sector. But there's a big question on everyone's mind: Is renewable energy just ...
waaree_feature_image-scaled.jpg
Stocks

PG Electroplast: Diversifying and scaling to ride India’s EMS growth story

PGEL is one the leading ODM players in the country manufacturing products like air conditioners and washing machines. India's Consumer Electronics Market is ...
PGEL_feature_image.jpeg
IPO

Niva Bupa Health Insurance: Structural tailwinds in play

Niva Bupa Health Insurance is one of the largest and fastest growing standalone health insurer (SAHI) in India and is coming up with an IPO to raise 2,200 Cr. ...
Untitled-design-3.jpg
Sector Analysis

Nuvama or 360 One: Who’s Ahead in Wealth Management?

The HNIs & UHNIs segment in India is growing at a faster pace than ever, and with that comes a growing demand for smarter money management. In this report, we ...
391BEC7D-FDB3-4B8F-BFF4-8E266369B6A7.jpeg
Stocks

Unfolding the Sudarshan-Heubach deal

Sudarshan Chemicals announced its acquisition of Heubach Group, a 200-year-old pigment giant, sending its stock soaring 20%. While the market reacted ...
75C3627B-5D70-41E3-A556-516D9C7AE985-scaled.jpeg
Stocks

Zen Tech: Spearheading Innovation in Defence

Are defense stocks losing their shine? Has the long-term growth trend reversed? We doubt it. While stocks in this sector were down anywhere between 20-35%, we ...
Group-93-2.jpg
Stocks

Which is the best REIT in India?

As the market anticipates a potential rate cut by RBI in the near future, InvITs & REITs as an asset class are well-positioned to benefit. With that in mind, ...
8BC13C09-42BC-488A-9B90-3DD65128D38E.jpeg
General

Navigating the F&O Landscape: Five Key Lessons from SEBI's Eye-Opening Study

Recently, SEBI published a study about the F&O trading activities in India. This is the second such study by the regulator to understand how profitable (or ...
90D17E5D-3E5F-4233-BFCB-6A33AF50C976.jpeg
Stocks

Which is the best InvIT in India?

Looks like InvITs have hit a bit of a rough patch recently. But hey, every cloud has a silver lining, right? Could this dip in price be a buying opportunity? ...
best_invit.jpg